ACS CAN Comments on Draft Laboratory Developed Test (LDT) Rule

FDA has proposed to end enforcement discretion with respect to regulating the performance of LDTs.  ACS CAN has long supported harmonizing and modernizing diagnostic oversight and supports the proposed rule.